Ferrer Internacional
CompanySpainFounded 1940
Ferrer Internacional develops 2 assets, the furthest in phase 3 (pridopidine in amyotrophic lateral sclerosis). Mostly small molecule acting on SIGMAR1, lipid and ceramide metabolism and inflammation; based in Spain, founded in 1940.
- 2
- Assets
- Furthest
- Phase 3
- 4
- Trials
- 0
- Signals
Pipeline
2Selective sigma-1 receptor agonist promoting neuroprotective pathways.
Phase 3, Small molecule, SIGMAR1, amyotrophic lateral sclerosis, Huntington's disease, Partner
Cardiovascular fixed dose combination pill (acetylsalicylic acid, simvastatin and ramipril)
Fixed-dose polypill combining acetylsalicylic acid, simvastatin, and ramipril for cardiovascular risk reduction
Phase 2, Small molecule, Lipid and ceramide metabolism, Inflammation, elevated ldl cholesterol
Full company profiles: pipeline, trials, funding and people.
See ProIn the full profile
- Evidence behind the mechanisms7
- Trials7
- Signals2
- Similar companies6
Updated 8 Oct 2026 · 17 sources